Organigram Global Inc. OGI
1.10
0.00
0.00%
as of 25 Sep
- Market cap
- $155.1M
- P/E
- 2.4×
Follow OGI
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 12.00 | 0.00 | 2.19 |
P/S ratio |
1.40 | 1.13 | 0.89 | 0.62 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(262.25) | (19.73) | (34.48) | (46.67) | |
P/B ratio |
1.04 | 0.86 | 0.65 | 0.39 | |
Price to Tangible BV |
1.46 | 1.17 | 0.86 | 2.19 | |
EV/Sales |
1.07 | 0.91 | 0.69 | 0.65 | |
EV/EBITDA |
104.00 | 20.89 | 0.00 | 15.62 | |
EV/Operating CF |
(36.65) | (13.03) | (18.04) | (7.04) | |
EV/FCF |
(11.34) | (6.88) | (8.68) | (6.84) | |
Quick Ratio |
1.18 | 1.20 | 1.22 | 0.93 | |
Current Ratio |
2.26 | 2.73 | 2.82 | 2.61 | |
Net Debt/EBITDA |
(7.69) | (40.31) | 3.69 | 0.61 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 2.56% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.04 | |
Asset Turnover |
0.53 | 0.55 | 0.53 | 0.45 | |
Operating CF/Net income |
0.04 | (0.80) | 7.62 | (0.04) | |
Capex/Depreciation |
0.22 | (0.42) | (0.05) | 0.05 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
3.94% | 3.28% | 3.39% | 2.09% | |
Selling, General and Administrative Expense of Revenue |
34.36% | 38.79% | 40.43% | 32.03% | |
Intangible Assets out of Total Assets |
0.18 | 0.19 | 0.18 | 0.49 | |
Share Based Compensation of Revenue |
1.12% | 1.21% | 1.24% | 1.13% | |
Graham Net Nets |
0.20 | 0.30 | 0.42 | (0.29) | |
Graham Number |
0.00 | 2.49 | 0.00 | 5.21 | |
Earnings Yield |
(5.42%) | 8.33% | (9.34%) | 45.58% | |
Free Cash Flow Yield |
(6.77%) | (11.64%) | (8.91%) | (15.34%) | |
Revenue per Share |
0.45 | 0.34 | 0.33 | 0.57 | |
Operating CF per Share |
(0.01) | (0.09) | (0.04) | (0.02) | |
Capex per Share |
0.01 | (0.01) | 0.00 | 0.00 | |
Free Cash Flow per Share |
0.00 | (0.10) | (0.04) | (0.02) | |
Cash per Share |
0.47 | 0.33 | 0.30 | 0.06 | |
Shareholders Equity per Share |
1.95 | 1.96 | 2.06 | 2.59 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.95 | 1.96 | 2.06 | 2.59 | |
Free Cash Flow |
(0.22) | (13.00) | (5.32) | (2.63) | |
Working Capital |
113.48 | 116.56 | 117.60 | 124.82 | |
Capital Expenditures |
0.77 | (1.51) | (0.20) | 0.33 | |
Net Current Asset Value |
51.34 | 68.38 | 73.32 | (39.52) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
(0.01) | 0.03 | 0.00 | 0.00 | |
Net Profit Margin |
(45.45%) | 31.43% | (1.54%) | 99.77% | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
36.84 | 34.73 | 36.86 | 52.80 | |
Average Payables |
49.21 | 48.11 | 48.59 | 68.55 | |
Average Inventory |
74.63 | 84.72 | 89.32 | 104.86 | |
Average Assets |
350.83 | 361.45 | 377.29 | 500.35 | |
Average Common Equity |
237.23 | 248.08 | 271.50 | 314.68 |
Columns are period end dates